raf, this is why we need Denner to be very proactive. Management and our goals do not align anymore. Back before Du, they did as everyone was expecting a buyout. That has now changed. The majority of us shareholders would accept something less than we would have in December 2019. For some $15, others $20 and so on, but we want it soon. Management has a plan that will take years to execute. They may not even get us to what they expect, but what they do get is 10's or even 100's of thousands of shares while time goes by. No skin off their back if after 3 or 4 years their plans don't work out or are marginal at best. They are being paid to wait. They literally can't lose unless the company goes bankrupt because even with a stagnant share price they all gained hundreds of thousands of shares. Give me half the free shares these guys get and I will gladly wait 3, 4 even 5 years, but don't think for second that they have your best interests or patients for that matter in mind. No one can convince me that sales in Germany would only have been $700k if a BP was involved. Seriously if it wasn't for Denner, I would have just sold based on this last earnings release which was just like every other release going back years. The only difference is KM speaks better than JT. As far as bold action, there is none.
AI
Market Data 
Markets 
